Personalized Neoantigen Vaccines Boost Progress Against Aggressive Cancers
Researchers at the AACR Annual Meeting 2024 presented the latest findings regarding two personalized neoantigen cancer vaccines.
Category: Research
Researchers at the AACR Annual Meeting 2024 presented the latest findings regarding two personalized neoantigen cancer vaccines.
Researchers are exploring new options for kidney cancer treatments.
Researchers are examining the gut microbiome to find better ways to diagnose and manage colorectal cancer.
This Trojan horse-like treatment strategy may help neutralize undruggable cancer drivers.
Researchers are finding early clinical success in developing more targeted treatments for bile duct cancer, also called cholangiocarcinoma.
In part 4 of our 2024 Experts Forecast, Paul Workman, PhD, shares thoughts on cutting-edge advances in oncology drug...
In part 3 of our 2024 Experts Forecast, AACR President-Elect Patricia M. LoRusso, DO, PhD (hc), FAACR, shares thoughts...
What experts forecast for cancer research and treatment in 2024. Part 1: Catherine J. Wu, MD, FAACR, on...
“What will you do Monday morning?” was the question posed by the final session on the final full day...
In 1994, at the age of 40, Ginny Mason, RN, began noticing some concerning differences in the size and...